Avacta

Showing 4 posts of 4 posts found.

First Patient Dosed in the US in Avacta’s AVA6000 Phase 1 Clinical Study

April 27, 2023
Research and Development Avacta

Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces that the …

mufid-majnun-oi20ehignd4-unsplash

Avacta’s lateral flow test can detect Delta variant

June 29, 2021
Manufacturing and Production Avacta, COVID-19, Delta variant, antigen lateral flow test

A study has shown that Avacta’s AffiDX antigen lateral flow test can detect the Delta variant of COVID-19. The test …

Avacta joins major US cancer centre for CAR-T immunotherapy development

November 2, 2016
Research and Development Avacta, Memorial Sloan Kettering Cancer Center

Biotherapeutic and research reagent developer Avacta has announced it will collaborate with New York’s Memorial Sloan Kettering Cancer Center (MSK, …

philippe_cotrel

Avacta appoints Philippe Cotrel as chief commercial officer

January 25, 2016
Manufacturing and Production, Research and Development Avacta

Cotrel joins Avacta from Abcam, where he held the role of commercial operations director.He will lead the Group’s commercial strategy …

The Gateway to Local Adoption Series

Latest content